![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Frequencies of Resistance-Associated Amino Acid Variants Detected by 454 Sequencing During Combination Treatment With Boceprevir Plus Pegintron (Peginterferon Alfa-2b)/Ribavirin in HCV (GT1)-Infected Subjects
|
|
|
Reported by Jules Levin EASL 2011 Berlin Germany March 30-Apr 2
J.A. Howe1*, P. Qiu1, R.A. Ogert1, P. Mendez1, C.A. Brass1, J. Albrecht1, R. Ralston2, R.J.O. Barnard1, D. Hazuda1
1Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA; 2Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA *John.howe@merck.com
![EASL1.gif](../images/041211/041211-3/EASL1.gif)
![EASL2.gif](../images/041211/041211-3/EASL2.gif)
![EASL3.gif](../images/041211/041211-3/EASL3.gif)
![EASL4.gif](../images/041211/041211-3/EASL4.gif)
![EASL5.gif](../images/041211/041211-3/EASL5.gif)
![EASL6.gif](../images/041211/041211-3/EASL6.gif)
![EASL7.gif](../images/041211/041211-3/EASL7.gif)
![EASL8.gif](../images/041211/041211-3/EASL8.gif)
![EASL9.gif](../images/041211/041211-3/EASL9.gif)
![EASL10.gif](../images/041211/041211-3/EASL10.gif)
![EASL11.gif](../images/041211/041211-3/EASL11.gif)
![EASL12.gif](../images/041211/041211-3/EASL12.gif)
![EASL13.gif](../images/041211/041211-3/EASL13.gif)
![EASL14.gif](../images/041211/041211-3/EASL14.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|